A Pan-Cancer Analysis of Transcriptome and Survival Reveals Prognostic Differentially Expressed LncRNAs and Predicts Novel Drugs for Glioblastoma Multiforme Therapy

A Pan-Cancer Analysis of Transcriptome and Survival Reveals Prognostic Differentially Expressed LncRNAs and Predicts Novel Drugs for Glioblastoma Multiforme Therapy

Numerous studies have identified various prognostic long non-coding RNAs (LncRNAs) in a specific cancer type, but a comprehensive pan-cancer analysis for prediction of LncRNAs that may serve as prognostic biomarkers is of great significance to be performed. Glioblastoma multiforme (GBM) is the most...

Full description

Bibliographic Details
Main Authors: Rongchuan Zhao, Xiaohan Sa, Nan Ouyang, Hong Zhang, Jiao Yang, Jinlin Pan, Jinhui Gu, Yuanshuai Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Genetics
Subjects:
pan-cancer
long noncoding RNA
prognosis
biomarker
glioblastoma multiforme
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2021.723725/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2021.723725/full

Similar Items